急性冠状动脉综合征的代谢组学进展
Progress in the Metabolomics of Acute Coronary Syndrome.
作者信息
Zhang Fu, Li Bo, Su Hongling, Guo Zhaoxia, Zhu Hai, Wang Aqian, Jiang Kaiyu, Cao Yunshan
机构信息
Department of Cardiology, Pulmonary Vascular Disease Center (PVDC), Gansu Provincial Hospital, 730000 Lanzhou, Gansu, China.
The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), 730000 Lanzhou, Gansu, China.
出版信息
Rev Cardiovasc Med. 2023 Jul 14;24(7):204. doi: 10.31083/j.rcm2407204. eCollection 2023 Jul.
Acute coronary syndrome (ACS) is a severe type of coronary heart disease (CHD) with increasing prevalence and significant challenges for prevention and treatment. Metabolomics is an emerging technology with intrinsic dynamics and flexibility to better delineate the phenotypic and metabolic alterations in organisms at the time of altered pathological states. It provides new insights into the complex pathological mechanisms of cardiovascular disease and contributes to the early detection, monitoring and evaluation of ACS. In this review, we analyze and summarize the literature related to ACS metabolomics which has contributed to the diagnosis and prevention of ACS.
急性冠状动脉综合征（ACS）是冠心病（CHD）的一种严重类型，其患病率不断上升，预防和治疗面临重大挑战。代谢组学是一项新兴技术，具有内在的动态性和灵活性，能够更好地描绘病理状态改变时生物体的表型和代谢变化。它为心血管疾病的复杂病理机制提供了新的见解，并有助于ACS的早期检测、监测和评估。在这篇综述中，我们分析并总结了与ACS代谢组学相关的文献，这些文献有助于ACS的诊断和预防。
Zotero 插件